260 related articles for article (PubMed ID: 30993355)
1. Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?
Wesson JA; Kolbach-Mandel AM; Hoffmann BR; Davis C; Mandel NS
Urolithiasis; 2019 Dec; 47(6):521-532. PubMed ID: 30993355
[TBL] [Abstract][Full Text] [Related]
2. Exploring mechanisms of protein influence on calcium oxalate kidney stone formation.
Berger GK; Eisenhauer J; Vallejos A; Hoffmann B; Wesson JA
Urolithiasis; 2021 Aug; 49(4):281-290. PubMed ID: 33587148
[TBL] [Abstract][Full Text] [Related]
3. Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal.
Kolbach-Mandel AM; Mandel NS; Hoffmann BR; Kleinman JG; Wesson JA
Urolithiasis; 2017 Aug; 45(4):337-346. PubMed ID: 28314883
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes.
Wesson JA; Zenka R; Lulich J; Eisenhauer J; Davis C
Urolithiasis; 2022 Dec; 50(6):653-664. PubMed ID: 36180755
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
Asokan D; Kalaiselvi P; Varalakshmi P
Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
[TBL] [Abstract][Full Text] [Related]
6. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
7. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
[TBL] [Abstract][Full Text] [Related]
8. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
Kalaiselvi P; Udayapriya KL; Selvam R
BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
10. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
Noonin C; Peerapen P; Yoodee S; Kapincharanon C; Kanlaya R; Thongboonkerd V
Chem Biol Interact; 2022 Apr; 357():109879. PubMed ID: 35263610
[TBL] [Abstract][Full Text] [Related]
12. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
14. Urinary calcium oxalate crystal growth inhibitors.
Worcester EM
J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
[TBL] [Abstract][Full Text] [Related]
15. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.
White DJ; Nancollas GH
Calcif Tissue Int; 1987 Feb; 40(2):79-84. PubMed ID: 3105837
[TBL] [Abstract][Full Text] [Related]
16. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
[TBL] [Abstract][Full Text] [Related]
17. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
18. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
19. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
20. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
Porile JL; Asplin JR; Parks JH; Nakagawa Y; Coe FL
J Am Soc Nephrol; 1996 Apr; 7(4):602-7. PubMed ID: 8724894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
